1. Cell Biology

Native adiponectin in serum binds to mammalian cells expressing T-cadherin, but not AdipoRs or calreticulin

  1. Shunbun Kita  Is a corresponding author
  2. Shiro Fukuda
  3. Norikazu Maeda
  4. Iichiro Shimomura
  1. Osaka University, Japan
https://doi.org/10.7554/eLife.48675
Share this article
Cite this article
  1. Shunbun Kita
  2. Shiro Fukuda
  3. Norikazu Maeda
  4. Iichiro Shimomura
(2019)
Native adiponectin in serum binds to mammalian cells expressing T-cadherin, but not AdipoRs or calreticulin
eLife 8:e48675.
https://doi.org/10.7554/eLife.48675
  2. Download BibTeX
  3. Download .RIS

Abstract

Adiponectin is an adipocyte-derived atypically abundant circulating factor that protects various organs and tissues through its receptors, AdipoRs, calreticulin, and T-cadherin. To identify the major binding partner of circulating native adiponectin, we expressed these receptors on the surface of HEK293 cells. Adiponectin, either that in mouse or human serum, purified from serum, or produced by mammalian cells, bound to cells expressing T-cadherin, but not to those expressing AdipoR1 or calreticulin. The stable introduction of T-cadherin and AdipoR1 into CHO cells resulted in the cell surface localization of these receptors. Native adiponectin in serum bound to cells expressing T-cadherin, not to those expressing AdipoR1. The knockdown of T-cadherin, but not AdipoRs resulted in the significant attenuation of native adiponectin binding to C2C12 myotubes. Therefore, native adiponectin binding depended on the amount of T-cadherin expressed in HEK293 cells, CHO cells, and C2C12 myotubes. Collectively, our mammalian cell-based studies suggest that T-cadherin is the major binding partner of native adiponectin in serum.

Data availability

All data were deposited in Dryad under https://dx.doi.org/10.5061/dryad.82557c0

The following data sets were generated

Article and author information

Author details

  1. Shunbun Kita

    Department of Metabolic Medicine, Osaka University, Suita, Japan
    For correspondence
    shunkita@endmet.med.osaka-u.ac.jp
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8937-0053

  2. Shiro Fukuda

    Department of Metabolic Medicine, Osaka University, Suita, Japan
    Competing interests
    The authors declare that no competing interests exist.

  3. Norikazu Maeda

    Department of Metabolic Medicine, Osaka University, Suita, Japan
    Competing interests
    The authors declare that no competing interests exist.

  4. Iichiro Shimomura

    Department of Metabolic Medicine, Osaka University, Suita, Japan
    Competing interests
    The authors declare that no competing interests exist.

Funding

CREST

  • Shiro Fukuda
  • Iichiro Shimomura

JST

  • Shiro Fukuda
  • Iichiro Shimomura

Grant in Aid for Scientific Research (#16K09802)

  • Shunbun Kita

Grant in Aid for Scientific Research (#16K09801)

  • Norikazu Maeda

Grant in Aid for Scientific Research (#15H04853)

  • Iichiro Shimomura

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. David E James, The University of Sydney, Australia

Ethics

Animal experimentation: The experimental protocol was approved as No. 28-072-023 by the Ethics Review Committee for Animal Experimentation of Osaka University School of Medicine. This study also conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health.

Version history

  1. Received: May 22, 2019
  2. Accepted: October 13, 2019
  3. Accepted Manuscript published: October 24, 2019 (version 1)
  4. Version of Record published: October 31, 2019 (version 2)

Copyright

© 2019, Kita et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,600
    views
  • 280
    downloads
  • 32
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Shunbun Kita
  2. Shiro Fukuda
  3. Norikazu Maeda
  4. Iichiro Shimomura
(2019)
Native adiponectin in serum binds to mammalian cells expressing T-cadherin, but not AdipoRs or calreticulin
eLife 8:e48675.
https://doi.org/10.7554/eLife.48675

Share this article

https://doi.org/10.7554/eLife.48675

Categories and tags

Research organisms

Further reading

    1. Cancer Biology
    2. Cell Biology

    A syngeneic spontaneous zebrafish model of tp53-deficient, EGFRvIII, and PI3KCAH1047R-driven glioblastoma reveals inhibitory roles for inflammation during tumor initiation and relapse in vivo

    Alex Weiss, Cassandra D'Amata ... Madeline N Hayes
    Research Article

    High-throughput vertebrate animal model systems for the study of patient-specific biology and new therapeutic approaches for aggressive brain tumors are currently lacking, and new approaches are urgently needed. Therefore, to build a patient-relevant in vivo model of human glioblastoma, we expressed common oncogenic variants including activated human EGFRvIII and PI3KCAH1047R under the control of the radial glial-specific promoter her4.1 in syngeneic tp53 loss-of-function mutant zebrafish. Robust tumor formation was observed prior to 45 days of life, and tumors had a gene expression signature similar to human glioblastoma of the mesenchymal subtype, with a strong inflammatory component. Within early stage tumor lesions, and in an in vivo and endogenous tumor microenvironment, we visualized infiltration of phagocytic cells, as well as internalization of tumor cells by mpeg1.1:EGFP+ microglia/macrophages, suggesting negative regulatory pressure by pro-inflammatory cell types on tumor growth at early stages of glioblastoma initiation. Furthermore, CRISPR/Cas9-mediated gene targeting of master inflammatory transcription factors irf7 or irf8 led to increased tumor formation in the primary context, while suppression of phagocyte activity led to enhanced tumor cell engraftment following transplantation into otherwise immune-competent zebrafish hosts. Altogether, we developed a genetically relevant model of aggressive human glioblastoma and harnessed the unique advantages of zebrafish including live imaging, high-throughput genetic and chemical manipulations to highlight important tumor-suppressive roles for the innate immune system on glioblastoma initiation, with important future opportunities for therapeutic discovery and optimizations.

    1. Cancer Biology
    2. Cell Biology

    Cancer: Modeling glioblastoma

    Ian Lorimer
    Insight

    Establishing a zebrafish model of a deadly type of brain tumor highlights the role of the immune system in the early stages of the disease.

    1. Cell Biology
    2. Neuroscience

    Presynaptic Rac1 in the hippocampus selectively regulates working memory

    Jaebin Kim, Edwin Bustamante ... Scott H Soderling
    Research Article

    One of the most extensively studied members of the Ras superfamily of small GTPases, Rac1 is an intracellular signal transducer that remodels actin and phosphorylation signaling networks. Previous studies have shown that Rac1-mediated signaling is associated with hippocampal-dependent working memory and longer-term forms of learning and memory and that Rac1 can modulate forms of both pre- and postsynaptic plasticity. How these different cognitive functions and forms of plasticity mediated by Rac1 are linked, however, is unclear. Here, we show that spatial working memory in mice is selectively impaired following the expression of a genetically encoded Rac1 inhibitor at presynaptic terminals, while longer-term cognitive processes are affected by Rac1 inhibition at postsynaptic sites. To investigate the regulatory mechanisms of this presynaptic process, we leveraged new advances in mass spectrometry to identify the proteomic and post-translational landscape of presynaptic Rac1 signaling. We identified serine/threonine kinases and phosphorylated cytoskeletal signaling and synaptic vesicle proteins enriched with active Rac1. The phosphorylated sites in these proteins are at positions likely to have regulatory effects on synaptic vesicles. Consistent with this, we also report changes in the distribution and morphology of synaptic vesicles and in postsynaptic ultrastructure following presynaptic Rac1 inhibition. Overall, this study reveals a previously unrecognized presynaptic role of Rac1 signaling in cognitive processes and provides insights into its potential regulatory mechanisms.